Clincosm LogoSign in Get a demo

Breast Cancer

Showing NaN - NaN of 209
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Breast Cancer
  • Birmingham, Alabama
  • +111 more
Oct 25, 2022

Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Badalona, Sant Cugat Del Vallès, Barcelona (Elacestrant)

Completed
  • Breast Cancer
  • Hormone Receptor Positive Breast Carcinoma
  • Badalona, Barcelona, Spain
  • +3 more
Oct 25, 2022

Breast Cancer Trial in Worldwide (DS-8201a)

Active, not recruiting
Has Results
  • Breast Cancer
  • Anchorage, Alaska
  • +98 more
Oct 17, 2022

Breast Cancer Trial in Worldwide (GDC-0032, Tamoxifen)

Completed
  • Breast Cancer
  • Paris, France
  • +13 more
Oct 11, 2022

Breast Cancer Trial in Barcelona, Madrid, Valencia (Talimogene laherparepvec, Atezolizumab)

Active, not recruiting
  • Breast Cancer
  • Barcelona, Spain
  • +3 more
Sep 27, 2022

Breast Cancer Trial in Spain (Alpelisib, Metformin, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Alicante, Spain
  • +17 more
Aug 23, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Ovarian Cancer, Breast Cancer Trial in Worldwide (Olaparib)

Enrolling by invitation
  • Ovarian Cancer
  • Breast Cancer
  • Boca Raton, Florida
  • +98 more
Aug 22, 2022

Breast Cancer Trial in Worldwide (LY3484356)

Recruiting
  • Breast Cancer
  • Atlanta, Georgia
  • +19 more
Aug 17, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +3 more
  • Chandler, Arizona
  • +226 more
Aug 11, 2022

Breast Cancer Trial in Worldwide (Abraxane, Paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Adelaide, South Australia, Australia
  • +66 more
Aug 10, 2022

Breast Cancer, Cancer Trial in Worldwide (Nivolumab, Anastrozole, Palbociclib)

Completed
Has Results
  • Breast Cancer
  • Cancer
  • Nivolumab
  • +2 more
  • Whittier, California
  • +35 more
Jul 14, 2022

Tumors, Breast Tumors, Breast Tumors, Triple-Negative Trial in Korea, Republic of, Spain, United States (CX-2009, CX-072)

Active, not recruiting
  • Neoplasms
  • +4 more
  • La Jolla, California
  • +41 more
Aug 5, 2022

First Line Therapy for Locally Advanced and/or Metastatic Breast

Completed
  • Breast Cancer
  • Córdoba, Andalucía, Spain
  • +35 more
Aug 4, 2022

Breast Cancer, Uterine Cancer, Ovarian Cancer Trial in Denmark, France, Spain (GEN1047 is a bispecific antibody that induces

Recruiting
  • Breast Cancer
  • +3 more
  • GEN1047 is a bispecific antibody that induces T-cell mediated cytotoxicity of B7H4-positive cells.
  • Copenhagen, Denmark
  • +5 more
Jul 25, 2022

Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)

Active, not recruiting
Has Results
  • Breast Cancer
  • Chandler, Arizona
  • +166 more
Jul 21, 2022

Breast Cancer Trial in Worldwide (biological, drug, other, procedure)

Active, not recruiting
  • Breast Cancer
  • nivolumab
  • +6 more
  • Mobile, Alabama
  • +255 more
Jul 21, 2022

Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)

Active, not recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +167 more
Jul 19, 2022

Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan)

Recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • San Diego, California
  • +90 more
Jul 19, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)

Active, not recruiting
Has Results
  • Breast Cancer
  • Anchorage, Alaska
  • +495 more
Jun 15, 2022

Breast Cancer Trial in Worldwide (Amcenestrant (SAR439859), Letrozole)

Terminated
Has Results
  • Breast Cancer
  • Tucson, Arizona
  • +31 more
Jun 27, 2022

Breast Cancer Trial in Worldwide (Liposomal doxorubicin HCl, Cyclophosphamide, Trastuzumab)

Completed
  • Breast Cancer
  • Liposomal doxorubicin hydrochloride
  • +4 more
  • Kufstein, Austria
  • +21 more
Jun 21, 2022

Breast Cancer, Breast Tumors, Quality of Life Trial in Barcelona (Xemio mobile application)

Recruiting
  • Breast Cancer
  • +3 more
  • Xemio mobile application
  • Barcelona, Catalonia, Spain
    Hospital Clínic
Jun 3, 2022